ArticleEuropean radiology2021

Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma.

E Reizine et al.PubMed ↗Publisher ↗

No numbers read from the abstract.